← Back to home

CHRONIC LYMPHOCYTIC LEUKAEMIA OR SMALL LYMPHOCYTIC LYMPHOMA WITH UNMUTATED IGHV

Clinical trials for CHRONIC LYMPHOCYTIC LEUKAEMIA OR SMALL LYMPHOCYTIC LYMPHOMA WITH UNMUTATED IGHV explained in plain language.

Never miss a new study

Get alerted when new CHRONIC LYMPHOCYTIC LEUKAEMIA OR SMALL LYMPHOCYTIC LYMPHOMA WITH UNMUTATED IGHV trials appear

Sign up with your email to follow new studies for CHRONIC LYMPHOCYTIC LEUKAEMIA OR SMALL LYMPHOCYTIC LYMPHOMA WITH UNMUTATED IGHV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug aims to keep aggressive blood cancer at bay

Disease control Not yet recruiting

This study is testing whether a drug called surovatamig can help control a specific, harder-to-treat type of blood cancer (CLL/SLL) after patients finish their first round of standard therapy. It will compare giving the drug as a follow-up 'maintenance' treatment against simply w…

Matched conditions: CHRONIC LYMPHOCYTIC LEUKAEMIA OR SMALL LYMPHOCYTIC LYMPHOMA WITH UNMUTATED IGHV

Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Apr 04, 2026 09:20 UTC

CHRONIC LYMPHOCYTIC LEUKAEMIA OR SMALL LYMPHOCYTIC LYMPHOMA WITH UNMUTATED IGHV

Get alerted when new CHRONIC LYMPHOCYTIC LEUKAEMIA OR SMALL LYMPHOCYTIC LYMPHOMA WITH UNMUTATED IGHV trials appear

New drug aims to keep aggressive blood cancer at bay